랩지노믹스

084650KOSDAQ자연과학 및 공학 연구개발업

55.8 / 100

Reference Date: 2026-07-24

Financial Score17.5 / 40

News Sentiment21.3 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Plunged 17.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Labgenomics specializes in genetic molecular diagnostics, including non-invasive prenatal testing (NIPT), cancer gene screening, and chromosomal abnormality detection. As the first company in South Korea to commercialize NIPT, it leads the market with its 'MomGuard' product line and continues to expand its portfolio with innovations like the LabGun COVID-19 assay and early Alzheimer's diagnostic kits.

Number of Employees

142people

Average Salary

49.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

0.33Industry Average 2.527.0Point

Half of industry avg (excellent)

ROE

-35.18Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

13.61Industry Average 7.310.5Point

1.9x industry avg (risky)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.0% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼180.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -16.1% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
랩지노믹스, 최대주주 지분 추가 매수…"주주가치 제고"
최대주주 루하갈락티코스의 추가 주식 매수로 주주가치 제고와 책임경영 강화가 기대되며, 기업 가치 상승에 긍정적 영향을 미칠 것으로 보인다.
Positive
랩지노믹스, 5대 1 주식병합 결정…"주가 안정성 제고"
랩지노믹스의 주식병합 결정으로 주가 안정성과 기업 가치 상승 기대.
Positive
랩지노믹스, 수익성 중심 사업 재편…"연간 턴어라운드 기반 마련"
랩지노믹스가 수익성 중심의 사업 재편으로 인해 올해 1분기 흑자 전환 및 연결 영업손실 감소를 달성하며 긍정적인 실적 개선을 보이고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 656Won52-week high 2,50552-week low 640

1-month return0.0Point

1m -17.59% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-14
Neutral주식등의대량보유상황보고서(일반)2026-07-14
Neutral주주명부폐쇄기간또는기준일설정2026-06-29
Neutral주식병합결정2026-06-29
Neutral주주총회소집결의2026-06-29